Malignant mixed mesodermal tumours: biology and clinical aspects

C Gourley; A Al-Nafussi; M Abdulkader; J F Smyth; H Gabra

Malignant mixed mesodermal tumours: biology and clinical aspects

C Gourley, A Al-Nafussi, M Abdulkader, J F Smyth, H Gabra

Research output: Contribution to journal › Article › peer-review

Abstract

Mixed mesodermal tumours (MMTs) are relatively rare gynaecological tumours that have been poorly studied in clinical and molecular terms. They are chemosensitive (at least initially), although ultimately they have a poor prognosis. The biology of the tumour is fascinating in view of its composition of both epithelial and mesenchymal entities. We review herein the literature on the clinical and biological aspects of this malignancy.

Original language	English
Pages (from-to)	1437-46
Number of pages	10
Journal	European journal of cancer (Oxford, England : 1990)
Volume	38
Issue number	11
Publication status	Published - Jul 2002

Keywords

Antineoplastic Agents
Combined Modality Therapy
Female
Genital Neoplasms, Female
Humans
Mixed Tumor, Malignant
Mixed Tumor, Mesodermal
Prognosis

Cite this

@article{b2a4542b3acf4c60bbab718d2fde2b6d,

title = "Malignant mixed mesodermal tumours: biology and clinical aspects",

abstract = "Mixed mesodermal tumours (MMTs) are relatively rare gynaecological tumours that have been poorly studied in clinical and molecular terms. They are chemosensitive (at least initially), although ultimately they have a poor prognosis. The biology of the tumour is fascinating in view of its composition of both epithelial and mesenchymal entities. We review herein the literature on the clinical and biological aspects of this malignancy.",

keywords = "Antineoplastic Agents, Combined Modality Therapy, Female, Genital Neoplasms, Female, Humans, Mixed Tumor, Malignant, Mixed Tumor, Mesodermal, Prognosis",

author = "C Gourley and A Al-Nafussi and M Abdulkader and Smyth, {J F} and H Gabra",

year = "2002",

month = jul,

language = "English",

volume = "38",

pages = "1437--46",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "PERGAMON-ELSEVIER SCIENCE LTD",

number = "11",

}

TY - JOUR

T1 - Malignant mixed mesodermal tumours

T2 - biology and clinical aspects

AU - Gourley, C

AU - Al-Nafussi, A

AU - Abdulkader, M

AU - Smyth, J F

AU - Gabra, H

PY - 2002/7

Y1 - 2002/7

N2 - Mixed mesodermal tumours (MMTs) are relatively rare gynaecological tumours that have been poorly studied in clinical and molecular terms. They are chemosensitive (at least initially), although ultimately they have a poor prognosis. The biology of the tumour is fascinating in view of its composition of both epithelial and mesenchymal entities. We review herein the literature on the clinical and biological aspects of this malignancy.

AB - Mixed mesodermal tumours (MMTs) are relatively rare gynaecological tumours that have been poorly studied in clinical and molecular terms. They are chemosensitive (at least initially), although ultimately they have a poor prognosis. The biology of the tumour is fascinating in view of its composition of both epithelial and mesenchymal entities. We review herein the literature on the clinical and biological aspects of this malignancy.

KW - Antineoplastic Agents

KW - Combined Modality Therapy

KW - Female

KW - Genital Neoplasms, Female

KW - Humans

KW - Mixed Tumor, Malignant

KW - Mixed Tumor, Mesodermal

KW - Prognosis

M3 - Article

C2 - 12110488

VL - 38

SP - 1437

EP - 1446

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 11

ER -

Malignant mixed mesodermal tumours: biology and clinical aspects

Abstract

Keywords

Fingerprint

Cite this